Cite

    Maurizio Severino et al.. “Established amyloid‐β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine.” Alzheimer's & dementia, vol. 4, no. 1, 2018, pp. 215–223. http://access.bl.uk/ark:/81055/vdc_100103114863.0x000004